OTC · Drug Manufacturers - Specialty & Generic

Laxai Pharma, Ltd. (LAXAF) Stock

$0.00 OTC: LAXAF Healthcare

Laxai Pharma, Ltd. is an American company that offers specialized contract research services.

Valuation

MetricValue
Price$0.00
Market Cap$475341
P/E Ratio—
P/B Ratio—
P/S Ratio—
EPS (TTM)—
52-Week High$4.00
52-Week Low—
Dividend Yield—

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity—
Current Ratio—

Latest News

Morgan Stanley Says Amazon, Microsoft, and Google's AI Spending Will Pay Off Big GuruFocus.com · Jul 30, 2026 RBC Raises Price Target on General Dynamics to $410 From $385, Keeps Sector Perform Rating MT Newswires · Jul 30, 2026 Tourmaline Oil Q2 Earnings Fall 65% YoY MT Newswires · Jul 30, 2026 BrandPilot AI Converts Fortune 50 Healthcare Trial into Ongoing Customer Engagement TMX Newsfile · Jul 30, 2026 Memory Prices Hit Arm's Royalties as Stock Falls 4% GuruFocus.com · Jul 30, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield—
Quick Ratio—
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALSEAlseres Pharmaceuticals, Inc. $0.01 +100.00% 0.00 $398255 0.00%
ELVAYEvolva Holding S.A. $1.16 +0.00% -23.01 $518242 0.00%
FLURFFluroTech Ltd. $0.00 — -2.34 $447175 0.00%
LTTSFLotus Ventures Inc. $0.01 -68.71% -0.48 $458846 0.00%
MSITFMedical Services International Inc. $0.00 — — $480000 0.00%

About Laxai Pharma, Ltd.

Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of expertise include biostatistics, various data management methodologies (such as electronic, hybrid, and paper-based systems), CDISC advisory, medical documentation, clinical trial monitoring, regulatory compliance, pharmacovigilance, and associated training initiatives. The company, which was initially named Nexgen Biofuels Ltd., officially adopted the name Laxai Pharma, Ltd. in February 2010. Its headquarters are located in Tampa, Florida.

Laxai Pharma, Ltd. (LAXAF) stock trades at $0.00 with a market capitalization of $475341.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides